PUBLISHER: KBV Research | PRODUCT CODE: 1093177
PUBLISHER: KBV Research | PRODUCT CODE: 1093177
Asia Pacific Analgesics Market Size, Share & Industry Trends Analysis Report By Type (Non-opioids and Opioids), By Route of Administration (Oral, Transdermal, Intravenous, Topical, and Rectal), By Country and Growth Forecast, 2022 - 2028
The Asia Pacific Analgesics Market would witness market growth of 7.2% CAGR during the forecast period (2022-2028).
Patients in pain should receive the most effective treatment possible. Outside of current palliative care, cancer treatment, and end-of-life care, opioids are not the primary medication for chronic pain. Non-opioid treatments, such as non-opioid drugs and nonpharmacological therapy, can relieve chronic pain while also being safer. To the degree practicable, non-opioid therapy should be used in the treatment of chronic pain. Identify and treat co-occurring mental health issues. Preferentially use first-line drug options. In patients who have failed non-invasive treatments, consider interventional therapies, such as corticosteroid injections
Non-opioid pain relievers, such as ibuprofen, acetaminophen, aspirin, and steroids are available over the counter or through prescriptions, and some people find that these are sufficient. Nondrug therapy, which can be used solely or in combination with drugs, helps some patients. A physician who specializes in physical medicine, as well as rehabilitation, may be able to design an exercise program for patients that improves their functional abilities while also reducing pain.
Consumers in numerous regional countries are less concerned with analgesic side effects. Self-medication rather than consulting a skilled physician for moderate pain and fever is a habit that is prevalent in a number of nations, most notably in India. Furthermore, consumers in most urban areas in the region are seeking quick and easy ways to relieve pain due to their extremely stressed lifestyles. This, together with the increase in purchasing power, has allowed analgesic demand and sales to increase over time. China is one of the largest pharmaceutical markets in the world, and it is thriving as a result of two primary factors, including large-scale capital investment and rapid productivity growth. These two factors indicate that the country would be a lucrative investment destination as well as a significant source of domestic savings. Since the 1970s, the country has been shifting from a low-income to a more market-oriented economy. China is experiencing a spike in the regional market due to its large-scale production capability and high analgesics consumption.
The China market dominated the Asia Pacific Analgesics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $3,391 Million by 2028. The Japan market is experiencing a CAGR of 6.5% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 7.8% during (2022 - 2028).
Based on Type, the market is segmented into Non-opioids and Opioids. Based on Route of Administration, the market is segmented into Oral, Transdermal, Intravenous, Topical, and Rectal. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Reckitt Benckiser Group PLC, Abbott Laboratories, Johnson & Johnson, Bayer AG, Endo International PLC, GlaxoSmithKline PLC, Pfizer, Inc., Sanofi S.A., and Eli Lilly And Company.
Scope of the Study
Market Segments covered in the Report:
By Type
- Non-opioids
- Opioids
By Route of Administration
- Oral
- Transdermal
- Intravenous
- Topical
- Rectal
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Companies Profiled
- AbbVie, Inc.
- Reckitt Benckiser Group PLC
- Abbott Laboratories
- Johnson & Johnson
- Bayer AG
- Endo International PLC
- GlaxoSmithKline PLC
- Pfizer, Inc.
- Sanofi S.A.
- Eli Lilly And Company
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Asia Pacific Analgesics Market, by Type
- 1.4.2 Asia Pacific Analgesics Market, by Route of Administration
- 1.4.3 Asia Pacific Analgesics Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Strategies deployed in Analgesics Market
Chapter 4. Asia Pacific Analgesics Market by Type
- 4.1 Asia Pacific Macro processing Market by Country
- 4.2 Asia Pacific Micro processing Market by Country
Chapter 5. Asia Pacific Analgesics Market by Route of Administration
- 5.1 Asia Pacific Oral Market by Country
- 5.2 Asia Pacific Transdermal Market by Country
- 5.3 Asia Pacific Intravenous Market by Country
- 5.4 Asia Pacific Topical Market by Country
- 5.5 Asia Pacific Rectal Market by Country
Chapter 6. Asia Pacific Analgesics Market by Country
- 6.1 China Analgesics Market
- 6.1.1 China Analgesics Market by Type
- 6.1.2 China Analgesics Market by Route of Administration
- 6.2 Japan Analgesics Market
- 6.2.1 Japan Analgesics Market by Type
- 6.2.2 Japan Analgesics Market by Route of Administration
- 6.3 India Analgesics Market
- 6.3.1 India Analgesics Market by Type
- 6.3.2 India Analgesics Market by Route of Administration
- 6.4 South Korea Analgesics Market
- 6.4.1 South Korea Analgesics Market by Type
- 6.4.2 South Korea Analgesics Market by Route of Administration
- 6.5 Singapore Analgesics Market
- 6.5.1 Singapore Analgesics Market by Type
- 6.5.2 Singapore Analgesics Market by Route of Administration
- 6.6 Malaysia Analgesics Market
- 6.6.1 Malaysia Analgesics Market by Type
- 6.6.2 Malaysia Analgesics Market by Route of Administration
- 6.7 Rest of Asia Pacific Analgesics Market
- 6.7.1 Rest of Asia Pacific Analgesics Market by Type
- 6.7.2 Rest of Asia Pacific Analgesics Market by Route of Administration
Chapter 7. Company Profiles
- 7.1 AbbVie, Inc. (Allergan PLC)
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 Recent strategies and developments:
- 7.1.5.1 Approvals and Trials:
- 7.2 Reckitt Benckiser Group PLC
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental and Regional Analysis
- 7.2.4 Research & Development Expenses
- 7.2.5 Recent strategies and developments:
- 7.2.5.1 Product Launches and Product Expansions:
- 7.3 Abbott Laboratories
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental and Regional Analysis
- 7.3.4 Research & Development Expense
- 7.3.5 Recent strategies and developments:
- 7.3.5.1 Product Launches and Product Expansions:
- 7.3.5.2 Approvals and Trials:
- 7.4 Johnson & Johnson
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental &Regional Analysis
- 7.4.4 Research & Development Expenses
- 7.5 Bayer AG
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Research & Development Expense
- 7.5.5 Recent strategies and developments:
- 7.5.5.1 Product Launches and Product Expansions:
- 7.6 Endo International PLC
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.6.4 Research & Development Expense
- 7.7 GlaxoSmithKline PLC
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expense
- 7.7.5 Recent strategies and developments:
- 7.7.5.1 Partnerships, Collaborations, and Agreements:
- 7.7.5.2 Geographical Expansions:
- 7.8 Pfizer, Inc.
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Regional & Segmental Analysis
- 7.8.4 Research & Development Expense
- 7.8.5 Recent strategies and developments:
- 7.8.5.1 Partnerships, Collaborations, and Agreements:
- 7.9 Sanofi S.A.
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 Research & Development Expense
- 7.10. Eli Lilly And Company
- 7.10.1 Company Overview
- 7.10.2 Financial Analysis
- 7.10.3 Regional Analysis
- 7.10.4 Research & Development Expenses
- 7.10.5 Recent strategies and developments:
- 7.10.5.1 Partnerships, Collaborations, and Agreements:
- 7.10.5.2 Geographical Expansions:
LIST OF TABLES
- TABLE 1 Asia Pacific Analgesics Market, 2018 - 2021, USD Million
- TABLE 2 Asia Pacific Analgesics Market, 2022 - 2028, USD Million
- TABLE 3 Asia Pacific Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 4 Asia Pacific Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 5 Asia Pacific Macro processing Market by Country, 2018 - 2021, USD Million
- TABLE 6 Asia Pacific Macro processing Market by Country, 2022 - 2028, USD Million
- TABLE 7 Asia Pacific Micro processing Market by Country, 2018 - 2021, USD Million
- TABLE 8 Asia Pacific Micro processing Market by Country, 2022 - 2028, USD Million
- TABLE 9 Asia Pacific Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 10 Asia Pacific Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 11 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
- TABLE 12 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
- TABLE 13 Asia Pacific Transdermal Market by Country, 2018 - 2021, USD Million
- TABLE 14 Asia Pacific Transdermal Market by Country, 2022 - 2028, USD Million
- TABLE 15 Asia Pacific Intravenous Market by Country, 2018 - 2021, USD Million
- TABLE 16 Asia Pacific Intravenous Market by Country, 2022 - 2028, USD Million
- TABLE 17 Asia Pacific Topical Market by Country, 2018 - 2021, USD Million
- TABLE 18 Asia Pacific Topical Market by Country, 2022 - 2028, USD Million
- TABLE 19 Asia Pacific Rectal Market by Country, 2018 - 2021, USD Million
- TABLE 20 Asia Pacific Rectal Market by Country, 2022 - 2028, USD Million
- TABLE 21 Asia Pacific Analgesics Market by Country, 2018 - 2021, USD Million
- TABLE 22 Asia Pacific Analgesics Market by Country, 2022 - 2028, USD Million
- TABLE 23 China Analgesics Market, 2018 - 2021, USD Million
- TABLE 24 China Analgesics Market, 2022 - 2028, USD Million
- TABLE 25 China Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 26 China Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 27 China Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 28 China Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 29 Japan Analgesics Market, 2018 - 2021, USD Million
- TABLE 30 Japan Analgesics Market, 2022 - 2028, USD Million
- TABLE 31 Japan Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 32 Japan Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 33 Japan Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 34 Japan Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 35 India Analgesics Market, 2018 - 2021, USD Million
- TABLE 36 India Analgesics Market, 2022 - 2028, USD Million
- TABLE 37 India Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 38 India Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 39 India Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 40 India Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 41 South Korea Analgesics Market, 2018 - 2021, USD Million
- TABLE 42 South Korea Analgesics Market, 2022 - 2028, USD Million
- TABLE 43 South Korea Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 44 South Korea Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 45 South Korea Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 46 South Korea Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 47 Singapore Analgesics Market, 2018 - 2021, USD Million
- TABLE 48 Singapore Analgesics Market, 2022 - 2028, USD Million
- TABLE 49 Singapore Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 50 Singapore Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 51 Singapore Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 52 Singapore Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 53 Malaysia Analgesics Market, 2018 - 2021, USD Million
- TABLE 54 Malaysia Analgesics Market, 2022 - 2028, USD Million
- TABLE 55 Malaysia Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 56 Malaysia Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 57 Malaysia Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 58 Malaysia Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 59 Rest of Asia Pacific Analgesics Market, 2018 - 2021, USD Million
- TABLE 60 Rest of Asia Pacific Analgesics Market, 2022 - 2028, USD Million
- TABLE 61 Rest of Asia Pacific Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 62 Rest of Asia Pacific Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 63 Rest of Asia Pacific Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 64 Rest of Asia Pacific Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 65 Key information - AbbVie, Inc.
- TABLE 66 Key information - Reckitt Benckiser Group PLC
- TABLE 67 Key Information - Abbott Laboratories
- TABLE 68 Key information - Johnson & Johnson
- TABLE 69 Key Information - Bayer AG
- TABLE 70 Key Information - Endo International PLC
- TABLE 71 Key Information - GlaxoSmithKline PLC
- TABLE 72 Key Information - Pfizer, Inc.
- TABLE 73 Key Information - Sanofi S.A.
- TABLE 74 Key Information - Eli Lilly And Company
List of Figures
- FIG 1 Methodology for the research
- FIG 2 Recent strategies and developments: Abbott Laboratories
- FIG 3 Recent strategies and developments: Eli Lilly And Company
